Platelet polyphosphate
What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?
How to treat cerebral venous and sinus thrombosis
Risk of stroke after surgery in patients with and without chronic atrial fibrillation
Incidence of arterial cardiovascular events after venous thromboembolism
Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population – the Tromsø study
High platelet reactivity is associated with myocardial infarction in premenopausal women
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin
Clinical implications of clopidogrel non-response in cardiovascular patients
G-protein β3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes–thrombolysis in myocardial infarction 16 trial
Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels
Quantitation of bleeding symptoms in children with von Willebrand disease
Clinical prediction rules for pulmonary embolism
Explanations for coagulation activation after air travel
Hormone replacement therapy and the risk of venous thromboembolism
Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism
Incidence and risk factors for pulmonary embolism in the postpartum period
D-dimer testing in pregnant patients
Pharmacogenetics of acenocoumarol in patients with extreme dose requirements
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population
Biomechanics in hemostasis and thrombosis
The mechanical properties of single fibrin fibers
Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation
Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor
Hot spots in TAFIa
Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor
The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics
A GPIb-IX-V complex signaling environment
The platelet glycoprotein GPIbβ intracellular domain participates in von Willebrand factor induced-filopodia formation independently of the Ser 166 phosphorylation site
The pro-apoptotic BH3-only protein Bim regulates cell cycle progression of hematopoietic progenitors during megakaryopoiesis
von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal disease
Thrombin upregulates the angiopoietin–Tie2 Axis
Application of the international normalized ratio in the scoring system for disseminated intravascular coagulation
Problems in laboratory testing
No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants?
Reversal of warfarin-induced over-anticoagulation with individualized dosing of oral vitamin K
The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months
Incidence and clinical outcomes of occult cancers detected by computed tomographic pulmonary angiography in patients with acute pulmonary embolism
Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
Gene variants associated with venous thrombosis
Strength and failure of fibrin fiber branchpoints
Subclinical deep venous thrombosis observed in 10% of hemophilic patients undergoing major orthopedic surgery
Coated-platelet levels may explain some variability in clinical phenotypes observed with severe hemophilia
New TET2 gene mutations in patients with myeloproliferative neoplasms and splanchnic vein thrombosis
Join ISTH